| User login |
| Browse archives |
| Who's online |
| Syndicate |
archives
Abbott Begins Post-Approval Study Of XIENCE V™ Drug Eluting Stent... |
Abbott announced the start of the XIENCE V USA post-approval study, with six hospital centers already recruiting and enrolling patients just one week after the U.S. Food and Drug Administration approved the XIENCE V Everolimus Eluting Coronary Stent System. The XIENCE V USA study will evaluate the safety and effectiveness of the XIENCE V drug eluting stent in a real-world clinical setting out t...
No more uphill struggles for cyclists... |
Home News Sport Business Your Say Newspaper site web Search Scotland UK International Politics Science & Technology Health Education Entertainment Gaelic Opinion Obituaries You need to have javascript enabled to view this page correctly
Your account has been frozen. For your available options click the below button.
To read this article in full you must have registered and have a Pr...